Author: Dr. Paolo Beconcini THE LATEST AMENDMENTS TO THE CHINESE PATENT LAW October 17, 2020, the 22nd Meeting of the Standing Committee of the Thirteenth National People’s Congress issued a Decision (hereafter and in the Footnotes “The Decision”), adopting the fourth set of amendments to the Patent Law of the People’s Republic of China[1] since…

Author: Dr. Paolo Beconcini 2020 China-E.U. Trade Investment Agreement and IP/Technology Theft On December 30, 2020, after seven long years of negotiations, China and the EU concluded negotiations for a Comprehensive Agreement on Investment (CAI). The frayed political and trade relations with the US, as well as Brexit, convinced the EU members to set aside…

Author: Dr. Paolo Beconcini (Head of the IP and Anti-Counterfeiting Team – China & APAC – at Squire Patton Boggs) The protection of intellectual property rights is a constant grievance in the trade disputes between China and the United States. As recently as 2018, China’s IP system’s alleged flaws were the immediate and formal cause for…

RIPL is excited to announce the publication of The China IP Blog Series: The Imminent Implications of the US-China Trade Agreement, Covid-19, Recent Decisions of the Supreme People’s Court, and Other Developments in the Chinese IP Regime by Dr. Paolo Beconcini of Squire Patton Boggs. The series will begin on Friday, January 22nd and will run through…